Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference

by NASDAQ Market News March 8, 2021

NASDAQ Market News
Click here to email author

AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test

The global sepsis diagnostics market is projected to grow at a CAGR of 8.06% during the forecast period, 2021-2028

Ads